Abstract
Cholesterol-based drug conjugates have a good potential for target-delivering therapeutic agents to various disease areas. Many studies have been conducted to develop new cholesteryl drug conjugates for the diagnosis, or treatment, of diseases related to liver, adrenals, ovaries, atherosclerotic lesions, viral infections and tumors. This review paper highlights these studies and their potential medical applications. The chemical structures of the new cholesteryl drug conjugates have also been reviewed to provide useful information for a further development in this area.